Targeting Components of Distress Tolerance
Launched by UNIVERSITY OF ARKANSAS, FAYETTEVILLE · Aug 21, 2024
Trial Information
Current as of July 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking to understand how people handle emotional distress, which is when someone struggles to cope with upsetting feelings. The researchers want to find out if being willing to feel upset and having confidence in managing distress can help people use better strategies to deal with their emotions in everyday life. The ultimate aim is to see if improving these skills can lead to fewer mental health problems over time.
To participate in this study, you need to be between the ages of 65 and 74, fluent in English, and have access to a smartphone with internet. You’ll need to have certain scores on tests that measure depression and distress to qualify. If you join, you'll spend three weeks answering questions on your mood and how you handle emotions using a smartphone app. You'll also take part in sessions at the lab where you'll learn different techniques to improve your emotional skills. Throughout the study, you will share weekly updates on your mental health. This trial is not yet recruiting participants, so if you're interested, keep an eye out for when it starts!
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Fluent in English
- • Uses Android or iPhone smartphone
- • Depression Anxiety and Stress Scale (DASS-21) scores of 42 and higher
- • Distress Intolerance Index (DII) scores of 3 or higher
- Exclusion Criteria:
- • Work or School that does not allow consistent access to phone (or is unsafe)
- • No internet access for completing follow-up surveys
About University Of Arkansas, Fayetteville
The University of Arkansas, Fayetteville, is a leading research institution dedicated to advancing health and medical knowledge through innovative clinical trials. With a strong commitment to scientific excellence, the university leverages its extensive academic resources and interdisciplinary collaboration to conduct rigorous research that addresses pressing health challenges. The institution fosters a supportive environment for both researchers and participants, ensuring ethical standards and the highest quality of care throughout the trial process. As a sponsor, the University of Arkansas aims to contribute to the development of new therapies and interventions that enhance patient outcomes and improve public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Fayetteville, Arkansas, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported